188 related articles for article (PubMed ID: 37456283)
21. Ultrasound and clinicopathological characteristics-based model for prediction of pathologic response to neoadjuvant chemotherapy in HER2-positive breast cancer: a case-control study.
Sui L; Yan Y; Jiang T; Ou D; Chen C; Lai M; Ni C; Zhu X; Wang L; Yang C; Li W; Yao J; Xu D
Breast Cancer Res Treat; 2023 Nov; 202(1):45-55. PubMed ID: 37639063
[TBL] [Abstract][Full Text] [Related]
22. Multi-parameter diffusion and perfusion magnetic resonance imaging and radiomics nomogram for preoperative evaluation of aquaporin-1 expression in rectal cancer.
Chen Y; Li B; Jiang Z; Li H; Dang Y; Tang C; Xia Y; Zhang H; Song B; Long L
Abdom Radiol (NY); 2022 Apr; 47(4):1276-1290. PubMed ID: 35166938
[TBL] [Abstract][Full Text] [Related]
23. A Nomogram to Predict Disease-Free Survival Following Neoadjuvant Chemotherapy for Triple Negative Breast Cancer.
Zhu M; Liang C; Zhang F; Zhu L; Chen D
Front Oncol; 2021; 11():690336. PubMed ID: 34745934
[TBL] [Abstract][Full Text] [Related]
24. Value of radiomics based on CE-MRI for predicting the efficacy of neoadjuvant chemotherapy in invasive breast cancer.
Li Q; Huang Y; Xiao Q; Duan S; Wang S; Li J; Niu Q; Gu Y
Br J Radiol; 2022 Oct; 95(1139):20220186. PubMed ID: 36005646
[TBL] [Abstract][Full Text] [Related]
25. Real-world data on breast pathologic complete response and disease-free survival after neoadjuvant chemotherapy for hormone receptor-positive, human epidermal growth factor receptor-2-negative breast cancer: a multicenter, retrospective study in China.
Guan D; Jie Q; Wu Y; Xu Y; Hong W; Meng X
World J Surg Oncol; 2022 Sep; 20(1):326. PubMed ID: 36175898
[TBL] [Abstract][Full Text] [Related]
26. Assessing the Early Response of Advanced Cervical Cancer to Neoadjuvant Chemotherapy Using Intravoxel Incoherent Motion Diffusion-weighted Magnetic Resonance Imaging: A Pilot Study.
Wang YC; Hu DY; Hu XM; Shen YQ; Meng XY; Tang H; Li Z
Chin Med J (Engl); 2016 Mar; 129(6):665-71. PubMed ID: 26960369
[TBL] [Abstract][Full Text] [Related]
27. Construction of Nomograms for Predicting Pathological Complete Response and Tumor Shrinkage Size in Breast Cancer.
Yan S; Wang W; Zhu B; Pan X; Wu X; Tao W
Cancer Manag Res; 2020; 12():8313-8323. PubMed ID: 32982426
[TBL] [Abstract][Full Text] [Related]
28. A CT-based deep learning radiomics nomogram for predicting the response to neoadjuvant chemotherapy in patients with locally advanced gastric cancer: A multicenter cohort study.
Cui Y; Zhang J; Li Z; Wei K; Lei Y; Ren J; Wu L; Shi Z; Meng X; Yang X; Gao X
EClinicalMedicine; 2022 Apr; 46():101348. PubMed ID: 35340629
[TBL] [Abstract][Full Text] [Related]
29. Application Value of Magnetic Resonance Radiomics and Clinical Nomograms in Evaluating the Sensitivity of Neoadjuvant Chemotherapy for Nasopharyngeal Carcinoma.
Hu C; Zheng D; Cao X; Pang P; Fang Y; Lu T; Chen Y
Front Oncol; 2021; 11():740776. PubMed ID: 34790570
[TBL] [Abstract][Full Text] [Related]
30. Quantitative intravoxel incoherent motion parameters derived from whole-tumor volume for assessing pathological complete response to neoadjuvant chemotherapy in locally advanced rectal cancer.
Xu Q; Xu Y; Sun H; Chan Q; Shi K; Song A; Wang W
J Magn Reson Imaging; 2018 Jul; 48(1):248-258. PubMed ID: 29281151
[TBL] [Abstract][Full Text] [Related]
31. [Construction of a nomogram prediction model for pathological complete response (pCR) of ipsilateral supraclavicular lymph node after neoadjuvant chemotherapy for breast cancer with first diagnosis of ipsilateral supraclavicular lymph node metastasis].
Lyu MH; Jiao DC; Wu JZ; Tian PQ; Ma YZ; Liu ZZ; Chen XC
Zhonghua Zhong Liu Za Zhi; 2022 Feb; 44(2):160-166. PubMed ID: 35184460
[No Abstract] [Full Text] [Related]
32. Efficacy evaluation of neoadjuvant chemotherapy in patients with HER2-low expression breast cancer: A real-world retrospective study.
Tang L; Li Z; Jiang L; Shu X; Xu Y; Liu S
Front Oncol; 2022; 12():999716. PubMed ID: 36605428
[TBL] [Abstract][Full Text] [Related]
33. Prediction of Tumor Shrinkage Pattern to Neoadjuvant Chemotherapy Using a Multiparametric MRI-Based Machine Learning Model in Patients With Breast Cancer.
Huang Y; Chen W; Zhang X; He S; Shao N; Shi H; Lin Z; Wu X; Li T; Lin H; Lin Y
Front Bioeng Biotechnol; 2021; 9():662749. PubMed ID: 34295877
[No Abstract] [Full Text] [Related]
34. Radiomics of MRI for the Prediction of the Pathological Response to Neoadjuvant Chemotherapy in Breast Cancer Patients: A Single Referral Centre Analysis.
Pesapane F; Rotili A; Botta F; Raimondi S; Bianchini L; Corso F; Ferrari F; Penco S; Nicosia L; Bozzini A; Pizzamiglio M; Origgi D; Cremonesi M; Cassano E
Cancers (Basel); 2021 Aug; 13(17):. PubMed ID: 34503081
[TBL] [Abstract][Full Text] [Related]
35. Development and Validation of a Nomogram for Individually Predicting Pathologic Complete Remission After Preoperative Chemotherapy in Chinese Breast Cancer: A Population-Based Study.
Hou N; Xiao J; Wang Z; Wu Y; Hou G; Guo L; Zhang J; Ling R
Clin Breast Cancer; 2020 Dec; 20(6):e682-e694. PubMed ID: 32713825
[TBL] [Abstract][Full Text] [Related]
36. Combined dynamic contrast-enhanced magnetic resonance imaging and diffusion-weighted imaging to predict neoadjuvant chemotherapy effect in FIGO stage IB2-IIA2 cervical cancers.
Zhang A; Song J; Ma Z; Chen T
Radiol Med; 2020 Dec; 125(12):1233-1242. PubMed ID: 32424659
[TBL] [Abstract][Full Text] [Related]
37. Multiparametric magnetic resonance imaging for predicting pathological response after the first cycle of neoadjuvant chemotherapy in breast cancer.
Li X; Abramson RG; Arlinghaus LR; Kang H; Chakravarthy AB; Abramson VG; Farley J; Mayer IA; Kelley MC; Meszoely IM; Means-Powell J; Grau AM; Sanders M; Yankeelov TE
Invest Radiol; 2015 Apr; 50(4):195-204. PubMed ID: 25360603
[TBL] [Abstract][Full Text] [Related]
38. Radiomics of Tumor Heterogeneity in Longitudinal Dynamic Contrast-Enhanced Magnetic Resonance Imaging for Predicting Response to Neoadjuvant Chemotherapy in Breast Cancer.
Fan M; Chen H; You C; Liu L; Gu Y; Peng W; Gao X; Li L
Front Mol Biosci; 2021; 8():622219. PubMed ID: 33869279
[TBL] [Abstract][Full Text] [Related]
39. Multivariate machine learning models for prediction of pathologic response to neoadjuvant therapy in breast cancer using MRI features: a study using an independent validation set.
Cain EH; Saha A; Harowicz MR; Marks JR; Marcom PK; Mazurowski MA
Breast Cancer Res Treat; 2019 Jan; 173(2):455-463. PubMed ID: 30328048
[TBL] [Abstract][Full Text] [Related]
40. [Risk factor analysis on anastomotic leakage after laparoscopic surgery in rectal cancer patient with neoadjuvant therapy and establishment of a nomogram prediction model].
Jiang W; Feng MY; Dong XY; Dong SM; Zheng JX; Liu XM; Liu WJ; Yan J
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Aug; 22(8):748-754. PubMed ID: 31422613
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
